Extracellular Citrate Is a Trojan Horse for Cancer Cells

被引:14
|
作者
Petillo, Agata [1 ]
Abruzzese, Vittorio [1 ]
Koshal, Prashant [1 ]
Ostuni, Angela [1 ]
Bisaccia, Faustino [1 ]
机构
[1] Univ Basilicata, Dept Sci, Lab Cell Biochem, Potenza, Italy
关键词
citrate; HepG2; IHH; ATP citrate lyase; histone acetylation; cancer; epigenetics; METABOLISM; LYASE; PROLIFERATION;
D O I
10.3389/fmolb.2020.593866
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The first intermediate in the mitochondrial tricarboxylic acid (TCA) cycle is citrate, which is essential and acts as a metabolic regulator for glycolysis, TCA cycle, gluconeogenesis, and fatty acid synthesis. Within the cytosol, citrate is cleaved by ATP citrate lyase (ACLY) into oxaloacetate (OAA) and acetyl-CoA; OAA can be used for neoglucogenesis or in the TCA cycle, while acetyl-CoA is the precursor of some biosynthetic processes, including the synthesis of fatty acids. Accumulating evidence suggests that citrate is involved in numerous physiological and pathophysiological processes such as inflammation, insulin secretion, neurological disorders, and cancer. Considering the crucial role of citrate to supply the acetyl-CoA pool for fatty acid synthesis and histone acetylation in tumors, in this study we evaluated the effect of citrate added to the growth medium on lipid deposition and histone H4 acetylation in hepatoma cells (HepG2). At low concentration, citrate increased both histone H4 acetylation and lipid deposition; at high concentration, citrate inhibited both, thus suggesting a crucial role of acetyl-CoA availability, which prompted us to investigate the effect of citrate on ACLY. In HepG2 cells, the expression of ACLY is correlated with histone acetylation, which, in turn, depends on citrate concentration. A decrease in H4 acetylation was also observed when citrate was added at a high concentration to immortalized human hepatic cells, whereas ACLY expression was unaffected, indicating a lack of control by histone acetylation. Considering the strong demand for acetyl-CoA but not for OAA in tumor cells, the exogenous citrate would behave like a trojan horse that carries OAA inside the cells and reduces ACLY expression and cellular metabolism. In addition, this study confirmed the already reported dual role of citrate both as a promoter of cell proliferation (at lower concentrations) and as an anticancer agent (at higher concentrations), providing useful tips on the use of citrate for the treatment of tumors.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Harnessing enucleated cancer cells as Trojan horse cell vaccines
    Fang, Wenli
    Jing, Zhangyan
    Li, Yuan
    Zhang, Zhirang
    Lin, Zhongda
    Yang, Zhaoxin
    Tian, Yishi
    Zhang, Chi
    Ma, Yumeng
    Hou, Linlin
    Meng, Fanqiang
    Liang, Xin
    Zhang, Xudong
    CELL REPORTS PHYSICAL SCIENCE, 2024, 5 (01):
  • [2] Polyploidy formation in cancer cells: How a Trojan horse is born
    Was, Halina
    Borkowska, Agata
    Olszewska, Aleksandra
    Klemba, Aleksandra
    Marciniak, Marta
    Synowiec, Agnieszka
    Kieda, Claudine
    SEMINARS IN CANCER BIOLOGY, 2022, 81 : 24 - 36
  • [3] Extracellular citrate and metabolic adaptations of cancer cells
    Parkinson, E. Kenneth
    Adamski, Jerzy
    Zahn, Grit
    Gaumann, Andreas
    Flores-Borja, Fabian
    Ziegler, Christine
    Mycielska, Maria E.
    CANCER AND METASTASIS REVIEWS, 2021, 40 (04) : 1073 - 1091
  • [4] Extracellular citrate and metabolic adaptations of cancer cells
    E. Kenneth Parkinson
    Jerzy Adamski
    Grit Zahn
    Andreas Gaumann
    Fabian Flores-Borja
    Christine Ziegler
    Maria E. Mycielska
    Cancer and Metastasis Reviews, 2021, 40 : 1073 - 1091
  • [5] Extracellular Vesicles - A Trojan Horse for Therapeutic Agent Delivery
    Breyne, Koen
    Ughetto, Stefano
    Parlea, Lorena
    Shapiro, Bruce
    Breakefield, Xandra O.
    MOLECULAR THERAPY, 2020, 28 (04) : 464 - 464
  • [6] Dendritic cells: The Trojan horse of malaria?
    Wykes, Michelle N.
    Horne-Debets, Joshua
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2012, 42 (06) : 583 - 587
  • [7] Autophagy and cancer metastasis: a Trojan horse
    Alizadeh, Javad
    Lorzadeh, Shahrokh
    Ghavami, Saeid
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (06) : 1145 - 1147
  • [8] Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse
    Nowakowski, Adam
    Drela, Katarzyna
    Rozycka, Justyna
    Janowski, Miroslaw
    Lukomska, Barbara
    STEM CELLS AND DEVELOPMENT, 2016, 25 (20) : 1513 - 1531
  • [9] Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy
    Mehterov, Nikolay
    Kazakova, Maria
    Sbirkov, Yordan
    Vladimirov, Boyan
    Belev, Nikolay
    Yaneva, Galina
    Todorova, Krassimira
    Hayrabedyan, Soren
    Sarafian, Victoria
    GENES, 2021, 12 (07)
  • [10] HIV and Mature Dendritic Cells: Trojan Exosomes Riding the Trojan Horse?
    Izquierdo-Useros, Nuria
    Naranjo-Gomez, Mar
    Erkizia, Itziar
    Carmen Puertas, Maria
    Borras, Francesc E.
    Blanco, Julia
    Martinez-Picado, Javier
    PLOS PATHOGENS, 2010, 6 (03):